文献速递肿瘤 PET/CT

腮腺Warthin瘤的18F-FDG PET/CT与FAP靶向PET/CT表现对比

Comparative 18 F-FDG PET/CT and FAP-targeted PET/CT Findings in Parotid Warthin Tumor.
PubMed 文献 · Clin Nucl Med · 2026-02-23

本文报告2例腮腺Warthin瘤,在18F-FDG PET/CT上呈明显摄取,而在68Ga-FAPI-04和68Ga-FAP-2286 FAP靶向PET/CT上无或仅轻微摄取。这种不一致的影像模式提示FAP靶向PET/CT可能有助于区分Warthin瘤与恶性肿瘤。

要点

  • 腮腺Warthin瘤在18F-FDG PET/CT上常呈明显摄取,易误判为恶性。
  • 2例Warthin瘤在68Ga-FAPI-04和68Ga-FAP-2286 PET/CT上无或仅轻微摄取。
  • FDG高摄取而FAP低摄取的不一致模式可能有助于鉴别Warthin瘤与恶性病变。

核心结论

  • 腮腺Warthin瘤在FAP靶向PET/CT上无或仅轻微摄取,与FDG高摄取形成不一致模式,可能有助于与恶性肿瘤鉴别。

研究设计与样本

  • 本文为2例腮腺Warthin瘤的病例报告,对比18F-FDG PET/CT与FAP靶向PET/CT表现。

主要发现

  • 2例腮腺Warthin瘤在18F-FDG PET/CT上均显示明显摄取。
  • 2例在68Ga-FAPI-04和68Ga-FAP-2286 FAP靶向PET/CT上无或仅轻微摄取。

临床怎么用

  • 对于FDG高摄取的腮腺病变,FAP靶向PET/CT无或轻微摄取可能提示Warthin瘤而非恶性。

局限性

  • 仅基于2例病例报告,样本量小,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Warthin tumor is the second most common benign parotid neoplasm and often shows marked uptake on 18 F-FDG PET/CT, frequently mimicking malignancy. In contrast, its imaging characteristics on fibroblast activation protein (FAP)-targeted PET/CT remain insufficiently defined. We report 2 cases of parotid Warthin tumors that demonstrated marked FDG uptake but absent or minimal uptake on FAP-targeted PET/CT using 68 Ga-FAPI-04 and 68 Ga-FAP-2286. This discordant imaging pattern suggests that FAP-targeted PET/CT may aid in distinguishing Warthin tumor from malignant lesions.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Cheng K, Xu T, Wang P, et al. Comparative 18 F-FDG PET/CT and FAP-targeted PET/CT Findings in Parotid Warthin Tumor. Clin Nucl Med. 2026. PMID: 41738886. doi:10.1097/RLU.0000000000006392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。